In our pan-cancer correlation analysis we found significant negative correlations of miR-29 cluster members with DUSP2 expression in various cancer types such as adrenocortical carcinoma, bladder, colorectal and kidney cancer, mesothelioma and uveal melanoma, but most prominent in thymoma. This evidence concerns the gene DUSP2 and thymoma.